Argá Medtech Completes Enrollment of Paroxysmal AF Cohort in the COHERENT-AF Pivotal IDE Study
Prospective, multicenter study evaluates the Coherent Sine Burst Electroporation Ablation Platform, a sine wave-based pulsed field ablation technology, in drug-refractory atrial fibrillation; persistent AF cohort enrollment continues SAN DIEGO, Nov. 11, 2026 /PRNewswire/ -- Argá Medtech,...
Covered in this story
Analyst targets on Coherent Corp.
- Stifel: at $327 · target $420 by Aug 2027 · Buy via Investing.com
- Raymond James: at $327 · target $448 by Aug 2027 · Strong Buy via Yahoo Finance
- Northland Securities: at $327 · target $280 by Aug 2027 · Market Perform via Yahoo Finance
“At” is the closing price nearest the day the target was reported, the price we score it from; it is not an earlier target. Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $COHR yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Coherent Corp. →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.